Vivera Pharmaceuticals ifatanya na Areum Bio LLC na Access Bio, Inc. kwagura ikwirakwizwa ryigihugu muguha uburenganzira bwo gukoresha ibyihutirwa COVID-19 ibizamini byihuse

Vivera Pharmaceuticals, Inc. hamwe nogukwirakwiza ibizamini byo gusuzuma Areum Bio LLC uyumunsi yatangaje ko hashyizweho umuyoboro woguhuza kwagura Access Bio, Inc. .Areum Bio isanzwe ikwirakwiza CareStart ™ COVID-19 yihuta ya antigen yakozwe na New Jersey ikora uruganda rwa Access Bio, kandi izashaka gushimangira ibikorwa byayo binyuze muri Vivera ihuza abantu benshi batanga ubuvuzi n’imiryango.
Nka kaminuza, ubucuruzi, indege, hamwe n’ahantu hahurira abantu benshi bakoresha ibizamini bisanzwe murwego rwo gusubira ku ishuri, akazi, ingendo, n'amasezerano y’ishyaka, kuboneka ibizamini byizewe bya COVID-19 biracyakenewe cyane.Imikorere ya EUA yemerewe na Point-of-Care (POC) CareStart test yihuta ya antigen, hamwe nubushobozi bwa Vivera bwo gukwirakwiza, bizafasha kubona ibisubizo byihuse byo kwisuzumisha.
Leta zunze ubumwe z’Amerika zageze ku ntambwe zikomeye mu gutsinda icyorezo cy’icyorezo, ariko kubera ko igipimo cy’inkingo kiri munsi y’urwego rwiza kandi iterabwoba ry’imiterere mishya rikomeje kugaragara ku isi hose, biracyakenewe ko igihugu gikomeza gukurikiza protocole ya COVID-19 kugeza gabanya ikwirakwizwa.Ubufatanye bwo gukwirakwiza hagati ya Vivera, Areum Bio na Access Bio bizorohereza ibizamini byihuse bishoboka.Nkumukwirakwiza wemewe wa CareStart testing kwipimisha antigen byihuse, Vivera irashaka kwagura ibikorwa byayo kugirango abashinzwe ubuzima n’abarwayi babone ibizamini byihuse kugira ngo bafashe umutekano w’abaturage bacu.
Umuyobozi mukuru wa Vivera Pharmaceuticals, Paul Edalat yagize ati: "Ubu bufatanye bwo kwerekana ibicuruzwa ni ubumwe bushya bwa Vivera."Ati: “Isosiyete yishimiye gukorana na Areum Bio na Access Bio mu gutanga ibizamini byihuse kandi byizewe na EUA byemewe na COVID-19 ku bigo nderabuzima ndetse n'abarwayi mu gihugu hose.Mu kwagura igipimo cy’ibizamini, Vivera izemeza ko abafatanyabikorwa bacu n’abarwayi, cyane cyane abaturage batishoboye batunzwe na benshi bashobora kugera ku bisubizo bifatika. ”
Perezida wa Areum Bio, Dr. Jong Kim yagize ati: "Aya ni amahirwe meza kuri Areum Bio yo gufatanya n’isosiyete izwi cyane y’imiti Vivera mu gukwirakwiza CareStart ™ COVID-19 yihuta yipimisha antigen mu gihugu hose."Ati: “Binyuze muri ubwo bufatanye, dukoresheje ubushake n'ubuhanga duhuriyemo, tuzashobora gutanga ibikoresho byihuse kandi byizewe ku baturage bo mu gihugu hose mu gihe gikwiye kandi cyiza.Twizera ko nibikoresho byubuvuzi bigezweho, nabyo nta gaciro bifite keretse bigabanijwe kubarwayi babikeneye.Kuri Areum Bio, twizera tudashidikanya ko tuzabigeraho ari uko ibikoresho byacu bishya bigera ku barwayi no kubitanga no kugera ku ntego zabo.Kubwibyo, burigihe dukora cyane., Kugemura ibicuruzwa byacu ku bakiriya mu buryo bwihuse kandi bunoze. ”
Binyuze mu bufatanye bwabo bwo gukwirakwiza, Vivera, Areum Bio, na Access Bio bizeye gushyigikira umutekano mu gihugu mu mutekano kandi nta nkomyi mu kongera uburyo bwo kwipimisha bwihuse mu gihugu hose.
CareStart ™ COVID-19 Ikizamini cya Antigen ni ikizamini cyo gukingira immunochromatografique ikoreshwa mu kumenya neza antigen nucleocapsid protein antigen ikomoka kuri SARS-CoV-2 mu ngero za nasofaryngeal cyangwa izuru ryakusanyirijwe mu buryo butaziguye ku bakekwaho Umuntu ufite COVID-19 bakekwaho kuba COVID-19 igihe bakekwaho kuba COVID-19 igihe baba bafite utanga ubuvuzi akora ibizamini bibiri muminsi itanu yambere uhereye igihe ibimenyetso byatangiriye, cyangwa kubantu badafite ibimenyetso cyangwa izindi mpamvu zibyorezo, byibuze amasaha 24 hagati yibizamini Kandi ntibirenza amasaha 48.
Kwipimisha bigarukira kuri laboratoire zemejwe n’ivugururwa rya Clinical Laboratory Impinduka (CLIA) yo mu 1988, 42 USC §263a, kandi izo laboratoire zujuje ibyangombwa bisabwa kugira ngo hakorwe ibizamini bito, bito, cyangwa bisonewe.Ikizamini cyemerewe gukoreshwa muri point-of-care (POC), ni ukuvuga, aho abarwayi bavura bakorera munsi yicyemezo cyo gusonerwa CLIA, ibyemezo byubahirizwa, cyangwa ibyemezo.
Kubindi bisobanuro, nyamuneka sura cyangwa utwandikire kuri LinkedIn, Facebook, Twitter cyangwa Instagram.
Areum Bio, LLC ni umugabuzi w’ibikoresho byubuvuzi byizewe kandi yashyizeho ubufatanye bwizewe na Access Bio, Inc. Areum Bio ni ishami rya Ivy Pharma Inc. rifite icyicaro i New Jersey.Isosiyete ikorana nabafatanyabikorwa benshi mubucuruzi kandi yashyizeho inzira zo gukwirakwiza kwisi yose.Usibye amateka yimyaka 15 yo gukwirakwiza muri Reta zunzubumwe zamerika, igomba Gufasha, Areum Bio nayo yahagurukiye gufasha mugukwirakwiza vuba ibikoresho byizewe bya coronavirus binyuze mumurongo mugari.Isosiyete yiyemeje gukomeza guteza imbere ubuzima rusange n’imibereho myiza y’abantu itanga ibikoresho byo gupima neza kandi byizewe mu gihe gikwiye.
Access Bio, Inc. ni uruganda ruzwi rwo kwisuzumisha ruherereye muri New Jersey, ruracyibanda ku bushakashatsi, iterambere no gutanga umusaruro wo gusuzuma indwara zanduza.Access Bio yiyemeje gukumira no gusuzuma hakiri kare indwara zandura binyuze mu bushakashatsi, guteza imbere no gukora muri vitro yihuta yo gusuzuma, biosensor n'ibicuruzwa bisuzumwa na molekile.Hashingiwe ku bikenewe cyane ndetse n’ubushobozi bwo gukora ibyiza, iyi sosiyete ikorana n’abafatanyabikorwa ku isi, barimo Fondasiyo ya Bill na Melinda Gates, Umuryango w’ubuzima ku isi, n’ikigega cy’umuryango w’abibumbye cyita ku bana.


Igihe cyo kohereza: Nyakanga-01-2021